| Financial Year |
March 31 2023 |
| Monetary Funds |
568,944,005.18 |
| Held-for-trading Financial Assets |
639,903,113.70 |
| Notes Receivable |
9,119,407.16 |
| Accounts Receivable |
456,468,262.34 |
| Advances to Suppliers |
6,833,225.23 |
| Other Receivables |
24,961,526.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,998,798.62 |
| Total Current Assets |
2,057,079,368.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
51,426,400.68 |
| Investment Properties |
91,625,936.89 |
| Fixed Assetes |
363,356,177.37 |
| Under-construction Projects |
251,193,558.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
190,850,332.47 |
| R&D expenses |
-- |
| Goodwill |
769,048.02 |
| Long-Term Deferred and Prepaid Expenses |
14,905,893.80 |
| Deferred Income Tax Assets |
56,974,563.37 |
| Other Non-Current Assets |
94,929,004.72 |
| Sub-Total of Non-Current Assets |
1,168,983,571.48 |
| Total Assets |
3,226,062,940.32 |
| Short-Term Loans |
1,474,738.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
182,366,943.28 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
168,131,031.44 |
| Taxes Payable |
17,869,860.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
240,305,064.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
36,923,905.29 |
| Other Current Liabilities |
46,905,858.61 |
| Sub-Total of Current Liabilities |
1,229,018,405.04 |
| Long-term Loans |
-- |
| Bonds Payable |
382,793,840.29 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,136,284.69 |
| Deferred Income Tax Liabilities |
585,467.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
416,343,488.06 |
| Total Liabilities |
1,645,361,893.10 |
| Paid-In Capital(Or Share Stock) |
196,039,516.00 |
| Capital Surplus |
642,064,776.61 |
| Surplus Reserve |
86,841,043.84 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
439,196,606.20 |
| Minority Stockholder's Interest |
96,489,835.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,484,211,212.07 |
| Owner's Equity（Stockholder's Equity） |
1,580,701,047.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,226,062,940.32 |
